Polyrizon Ltd. PLRZ

Healthcare — Biotechnology

10.78 0.27 2.57% as of 25 Sep

Market cap: $24.9M
P/E: —

Follow PLRZ

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Jun '24	Dec '24	Jun '25	Dec '25
ROE Full definition →	+2 more TTM periods Free account	—	—	0.00%	0.00%
ROA Full definition →		—	—	0.00%	0.00%
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Free Cash Flow per Share Full definition →		—	0.00	0.00	0.00
Free Cash Flow Full definition →		—	(3.15)	(3.85)	(7.84)
Capital Expenditures Full definition →		—	—	0.00	(0.01)
Piotroski F-Score Full definition →		0.00	0.00	0.00	0.00
Other line items
Cash ROIC Full definition →		0.00%	(40.22%)	(11.23%)	(23.41%)
Operating CF/Net income Full definition →		—	0.00	0.00	0.00
Depreciation/Fixed assets Full definition →		0.00	0.00	31.20	0.00
Capex/Depreciation Full definition →		—	0.00	(0.02)	(0.01)
Operating CF per Share Full definition →		—	0.00	0.00	0.00
Capex per Share Full definition →		—	—	0.00	0.00
Capex to Sales Full definition →		—	—	0.00	0.00

Fold the line items

Columns are period end dates